Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
<h4>Background</h4>Papua New Guinea (PNG) has a high burden of lymphatic filariasis (LF) caused by Wuchereria bancrofti, with an estimated 4.2 million people at risk of infection. A single co-administered dose of ivermectin, diethylcarbamazine and albendazole (IDA) has been shown to have...
-д хадгалсан:
Үндсэн зохиолчид: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Ном |
Хэвлэсэн: |
Public Library of Science (PLoS),
2022-02-01T00:00:00Z.
|
Нөхцлүүд: | |
Онлайн хандалт: | Connect to this object online. |
Шошгууд: |
Шошго нэмэх
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|
Интернэт
Connect to this object online.3rd Floor Main Library
Зохиогчийн тэмдэгт: |
A1234.567 |
---|---|
Хуулбар 1 | Бэлэн |